Webinar

Advanced ELISA-MS™ for Host Cell Protein (HCP) coverage and ELISA Antibody Characterisation

Your registration was successful, so you can now watch and attend the on-demand presentation.

If you know a colleague who would benefit from this presentation, use the form to invite them.

After watching the presentation(s), please take a moment to share your extremely valuable insights. It will only take a few minutes.

Advanced ELISA-MS™ for Host Cell Protein (HCP) coverage and ELISA Antibody CharacterisationAnette Draborg, PhD

Panel Discussion

Presenters / Panellists

Presenters / Panellists
Anette Draborg, PhDSubject-matter expert in ELISA characterisationAlphalyse (Denmark)Anette Draborg, PhD, is a subject-matter expert in ELISA characterisation at Alphalyse, where she applies her extensive research experience in immunology and immunochemical assay development to support biopharmaceutical clients. She specialises in ELISA-MS™ coverage assessment, which combines immunocapture with liquid chromatography-mass spectrometry (LC-MS) to assess the suitability of ELISAs for Host Cell Protein (HCP) detection and control. Since joining Alphalyse in 2021, Anette has helped numerous clients evaluate the performance of their HCP-ELISAs using ELISA-MS™, ensuring fit-for-purpose assays that meet regulatory expectations and support the development of safe biologics.
Ejvind Mørtz, PhDCo-Founder & COOAlphalyse (Denmark)Ejvind holds a PhD from the University of Southern Denmark in Protein Chemistry & Molecular Biology. He has more than 20 years of experience developing protein analyses and mass spectrometry methods in the research & development of protein biologics, vaccines, monoclonal antibodies, therapeutic proteins, and cell and gene therapies.
Søren Skov Jensen, PhDAssociate DirectorHemab Therapeutics (Denmark)Søren Skov Jensen, M.Sc., PhD, serves as Associate Director, CMC Analytical Development at Hemab Therapeutics. He has over 14 years of experience in the biotechnology industry and has worked on therapeutics ranging from peptides to proteins and monoclonal antibodies across early- and late-stage development. Søren holds a PhD in Biochemistry and Molecular Biology from the University of Southern Denmark.

Moderators

Moderators
Dr. Ewoud van TrichtScientific DirectorBioQCExpert in (bio)pharmaceutical analysis with over 18 years of industrial experience in analytical development, Quality Control, and Analytical Quality by Design (AQbD). He has contributed to diverse therapeutic modalities, including small molecules, viruses, and cells, at leading companies such as Janssen Vaccines and Sanofi Cell Therapy.
Prof. Dr. Cari Sänger-van de GriendScientific DirectorBioQCExpert in (bio)pharmaceutical analytical chemistry with 30 years of industrial and academic experience in method development and control strategies, including Analytical Quality by Design (AQbD), and focused on best practices and knowledge sharing.

In Collaboration with:

Ask a Question

Join the conversation (or start a discussion) on the BioQC User Community.

 

Contact Us

If you have any questions about the event, don’t hesitate to get in touch with the BioQC Team: Feedback & General Enquiry